Superficial Radio Therapy is the premier choice for physicians and patients when it comes to skin cancer treatment options. With the SRT-100 Vision for Skin Cancer Treatment, physicians and patients alike, are privileged to witness the results through high-frequency ultrasound imaging. Key Features Laser Positioning System The SRT-100 Vision provides a laser positioning system for […]
Blog
Sensus Healthcare to Host First Quarter 2018 Financial Results and Business Update Conference Call on May 3, 2018
BOCA RATON, Fla., April 26, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that management will hold a conference call on Thursday, May 3, 2018 at 4:30 p.m. Eastern time to discuss the financial results […]
Sensus Healthcare Expands International Business to Meet Rising Patient Demand for Non-Invasive Skin Cancer and Keloid Treatments
EVP Rick Golin Assumes New Role Bringing Superficial Radio Therapy to International Distributors in Asia, the Americas, Europe and the Middle East BOCA RATON, Fla., April 19, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced […]
Sensus at the 2018 Texas Dermatological Society Users Meeting
Join Sensus Healthcare at the 2018 Texas Dermatological Society Users Meeting in Austin, TX April 27-28, 2018. For tickets and more information click here.
Sensus Healthcare at ASLMS 2018
Join Sensus Healthcare at the 2018 ASLMS conference in Dallas, TX April 11-15, 2018. Come and meet the new Sensus Laser Systems. Click here to register today!
Educating Your Patients on Keloid Removal Success Rates
A keloid is a cutaneous mass that characteristically develops following a dermal injury. The keloid has beset dermatologists and cosmetic surgeons for decades, in view of both its pathological evolution and therapeutic challenges. Classically described as an overgrowth of tissue that extends beyond the borders of the original wound, keloids differ from that of hypertrophic […]
Tony Perkins: A Keloid Treatment after Removal Success Story in the Making
Tony Perkins is a public school teacher in St. Louis. Mr. Perkins has suffered with keloids on his neck and torso for 15 years. Although keloids are benign growths, the weight of them has caused neck pain for Tony. He had undergone several surgeries previously and noticed that the keloids would return within a few […]
Skin Cancer and SRT – Jeff Goldstein Interview
Jeff Goldstein is a double lung transplant recipient and a multiple skin cancer survivor. Transplant recipients are immune compromised and has a pre-disposition to skin cancer. As a Floridian, Jeff spent a lot of time out in the Miami sun without sunscreen. Due to the sun exposure leading to skin cancer, Jeff has undergone over […]
Physician Spotlight – March 2018
Daniel J. Ladd, Jr., DO is the Medical Director and Founder of Tru-Skin Dermatology in Austin, Texas and the 2018 President-Elect of the AOCD. He earned his BA from the University of Texas at Austin and received his medical degree from Des Moines University in 1999. He completed his Dermatology residency at the Northeast Regional […]
Sensus Healthcare to Present at the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium
BOCA RATON, Fla., March 8, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), and multi-platform state of the art aesthetic lasers, today announced the Company will present at the B. Riley FBR Inaugural China Healthcare Investing […]
Sensus Healthcare Launches New Line of Laser Systems to Provide Patients with Full Spectrum of Clinical and Aesthetic Dermatological Solutions
Lasers Address Acne Lesion Correction, Hair Removal and Tattoo Removal, Among Other Applications BOCA RATON, Fla., March 5, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced today that the Company has launched Sensus Laser Systems, […]
Skin Cancer, Take a Hike! – Following the Journey of Dr. Dan Siegel
It is estimated that someone dies from melanoma ever hour, and one in five Americans will be diagnosed with skin cancer. However, when skin cancer is detected early, it has a 98% cure rate. Dr. Dan Siegel is embarking on a journey through the Alaskan wilderness to spread awareness, detection and prevention of skin cancer […]
What Does Basal Cell Carcinoma Look Like?
Basal cell carcinoma is a form of skin cancer that grows on areas of skin that are exposed to a lot of sunlight and UV radiation. If you’ve found a suspicious-looking spot on your skin that you think might be basal cell carcinoma, it’s natural to feel worried and scared. This is why it’s important […]
The Benefits of Treating Non-Melanoma Skin Cancer with Superficial Radio Therapy
When patients are diagnosed with non-melanoma skin cancers like basal cell carcinoma and squamous cell carcinoma, the first questions they ask are typically along the lines of… What does this mean? How serious is this? Is this life threatening? What is the survival rate? How can this be treated? That last question tends to be […]
Dr. Kevin Schewe, M.D. Discusses SRT
Dr. Kevin Schewe, M.D. discusses the early signs and symptoms of skin cancer plus the revolutionary treatment of SRT. View the full interview with 9News.com here.
NBNA – SRT-100, Game Changer for Keloid Treatment
Dr. Michael H. Gold, a previously featured physician in our Physician Spotlight, has been featured in the Fall 2017 issue of National Black Nurses Association News. Read the article here. SRT-100, Game Changer for Keloid Treatment Treating keloids is very frustrating, not only for the patient suffering from them, but also for the health care […]
Sensus Healthcare Opens Tel Aviv Office to Expand Footprint in Israel, the Middle East & Europe
BOCA RATON, Fla., Feb. 7, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced today that the Company is opening a new office in Tel Aviv to deepen its presence in Israel, the Middle East and […]
Sensus Healthcare Launches Collaboration with BirchBioMed to Treat and Prevent Scarring for Keloids Patients Around the World
BOCA RATON, Fla., Feb. 5, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced today Sensus’ collaboration with BirchBioMed Inc., a biomedical company focused on anti-scarring drugs, to treat and prevent scarring more effectively for patients […]
The Surgeon General’s Call to Action to Prevent Skin Cancer
The Surgeon General has released a Call to Action to address Skin Cancer as a major public health problem. The executive summary includes strategies for prevention with clear and concisely outlined goals. Click the link below to read the full article. The Surgeon General’s Call to Action to Prevent Skin Cancer
Sensus Healthcare Reports Record Revenue for 2017 Fourth Quarter and Full Year
Ninth consecutive quarter of double-digit year-over-year revenue growth Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Feb. 1, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results for the three […]